Rajendra K. Agrawal, Ph.D.
    Molecular mechanism of HflX-mediated drug resistance in mycobacteria (Majumdar et al., 2025).
    Molecular mechanism of HflX-mediated drug resistance in mycobacteria (Majumdar et al., 2025).
    Structure of a starvation sensing mycobacterial ribosome complex (Li and Majumdar et al., 2023)
    Structure of a starvation sensing mycobacterial ribosome complex (Li and Majumdar et al., 2023)
    Structure of the ribosome from Lyme disease-causing bacteria, Borrelia burgdorferi, with three distinctive ribosomal proteins (Sharma et al., 2023)
    Structure of the ribosome from Lyme disease-causing bacteria, Borrelia burgdorferi, with three distinctive ribosomal proteins (Sharma et al., 2023)
    Structure of the human mitochondrial ribosome recycling complex (Koripella et al., 2021)
    Structure of the human mitochondrial ribosome recycling complex (Koripella et al., 2021)
    Unique interactions between the human mitochondrial ribosomal components and tRNAs (Koripella and Sharma et al., 2020).
    Unique interactions between the human mitochondrial ribosomal components and tRNAs (Koripella and Sharma et al., 2020).

Rajendra K. Agrawal, PhD

Director, Division of Translational Medicine, Wadsworth Center
Professor, Department of Biomedical Sciences, University at Albany
PhD, Banaras Hindu University, India
Postdoctoral training: Wadsworth Center

Research Interests

Structure and Function of Cell’s Protein-Synthesizing “Machine”

The Agrawal Laboratory studies the mechanism of protein-synthesis, or gene translation, in humans and in pathogenic bacteria. Ribosomes, which lie at the center of the protein synthesis machinery, conduct protein synthesis in all organisms. While the bacterial ribosomes are the major targets of antibiotics, defects in human mitochondrial ribosomes (mitoribosomes) and translation cause multiple devastating genetic diseases. A deep understanding of ribosome structure and function in humans and pathogenic bacteria is necessary for designing or identifying drug targets so that safer drugs can be designed without affecting the human translational machinery.  The Agrawal Lab’s emphasis is on (i) human mitochondrial, and (ii) mycobacterial ribosomes. His lab uses biochemical, molecular biology, and high-resolution cryo-electron microscopy (cryo-EM) techniques to study these biological systems.  

The goal of studies in the Agrawal Lab includes the elucidation of mechanisms by which (i) leaderless mRNAs are recruited to the ribosomes, and (ii) unique component ribosomal proteins and translational factors participate in the process of mitochondrial protein synthesis. His lab was first do determine the structure of a mammalian mitochondrial ribosome. To study mycobacterial protein synthesis, the Agrawal Lab collaborates with other Wadsworth investigators. In collaboration with the Ojha Lab, his lab was first to determine structure of an alternative form of mycobacterial ribosome, revealing unique features of mycobacterial ribosome hibernation that has implications in mycobacterial dormancy and drug resistance. More recent work from his lab, in collaboration with the Ghosh Lab at the Wadsworth Center, revealed a novel molecular mechanism by which the mycobacteria negate the effect of ribosome-binding antibiotics, leading to drug resistance.   

Studies in the Agrawal Lab allow him to track conformational transitions undergone by the ribosome and its ligands during protein synthesis. Knowledge of specific conformational transitions is key to understanding the molecular mechanisms of protein synthesis itself, as well as the actions of antibiotics that target the bacterial ribosome or ribosomal ligands to inhibit such transitions. Comparison of results obtained for the bacterial ribosome complexes with those for the host cytosolic and mitochondrial ribosome complexes provides useful information that can lead to identification of new drug targets.

Select Publications
Majumdar S, Kashyap A, Koripella RK, Sharma MR, Hurst-Hess K, Manjari SR, Banavali NK, Ghosh P, Agrawal RK. HflX-mediated drug resistance through ribosome splitting and rRNA disordering in mycobacteria. Proc Natl Acad Sci U S A. 2025; Feb 11;122 (6): e2419826122. DOI: 10.1073/pnas.2419826122
Sharma MR, Manjari SR, Agrawal EK, Keshavan P, Koripella RK, Majumdar S, Marcinkiewicz AL, Lin YP, *Agrawal RK, *Banavali NK. The structure of a hibernating ribosome in a Lyme disease pathogen. Nature Comm. 2023; Oct 31;14 (1): 6961. DOI: 10.1038/s41467-023-42266-7 [* co-corresponding authors]
Agrawal RK, Majumdar S. Evolution: Mitochondrial Ribosomes Across Species. Methods Mol Biol. 2023; 2661 7-21. DOI: 10.1007/978-1-0716-3171-3_2
Koripella RK, Deep A, Agrawal EK, Keshavan P, Banavali NK, Agrawal RK. Distinct mechanisms of the human mitoribosome recycling and antibiotic resistance. Nature Comm. 2021; Jun 14;12 (1): 3607. DOI: 10.1038/s41467-021-23726-4
Koripella RK, Sharma MR, Bhargava K, Datta PP, Kaushal PS, Keshavan P, Spremulli LL, Banavali NK, and Agrawal RK. Structures of the human mitochondrial ribosome bound to EF-G1 reveal distinct features of mitochondrial translation elongation. Nature Comm. 2020; 11 (1): 3830. DOI: 10.1038/s41467-020-17715-2
Koripella RK, Sharma MR, Risteff P, Keshavan P, Agrawal RK. Structural insights into unique features of the human mitochondrial ribosome recycling. Proc Natl Acad Sci U S A. 2019; 116 (17): 8283-8288. DOI: 10.1073/pnas.1815675116
Koripella RK, Sharma MR, Haque ME, Risteff P, Spremulli LL, Agrawal RK. Structure of Human Mitochondrial Translation Initiation Factor 3 Bound to the Small Ribosomal Subunit. iScience. 2019; Feb 22 (12): 76–86. DOI: 10.1016/j.isci.2018.12.030
Li Y, Sharma MR, Koripella RK, Yang Y, Kaushal PS, Lin Q, Wade JT, Gray TA, Derbyshire KM, *Agrawal RK, *Ojha AK. Zinc depletion induces ribosome hibernation in mycobacteria. Proc Natl Acad Sci U S A. 2018; 115 (32): 8191-8196. DOI: 10.1073/pnas.1804555115 [* co-corresponding authors]
Shaikh TR, Yassin AS, Lu Z, Barnard D, Meng X, Lu TM, Wagenknecht T, Agrawal RK. Initial bridges between two ribosomal subunits are formed within 9.4 milliseconds, as studied by time-resolved cryo-EM. Proc Natl Acad Sci U S A. 2014; 111 (27): 9822-7. DOI: 10.1073/pnas.1406744111
Yassin AS, Haque ME, Datta PP, Elmore K, Banavali NK, Spremulli LL, Agrawal RK. Insertion domain within mammalian mitochondrial translation initiation factor 2 serves the role of eubacterial initiation factor 1. Proc Natl Acad Sci U S A. 2011; Mar 8;108 (10): 3918-23. DOI: 10.1073/pnas.1017425108
Sharma MR, Koc EC, Datta PP, Booth TM, Spremulli LL, Agrawal RK. Structure of the mammalian mitochondrial ribosomes reveals an expanded functional role for its component proteins. Cell. 2003; 115 (1): 97-108. DOI: 10.1016/s0092-8674(03)00762-1
Frank J, Agrawal RK. A ratchet-like inter-subunit reorganization of the ribosome during translocation. Nature. 2000; 406 (6793): 318-322. DOI: 10.1038/35018597
Full publication listing